Retatrutide
GLP-1/GIP/glucagon triple agonist · research material
ALO-P-003-10MG · In stock
Ordering 10+ vials of Retatrutide? 10+ vials of one compound are 40% off that compound, and 50+ vials are 50% off the whole order — confirmed on your order before payment.
For laboratory research use only. Not for human or veterinary use. Not a drug, food, supplement or cosmetic, and not intended to diagnose, treat, cure or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
- Lot number printed on every vial
- Each lot gets its own public record
- Purity by RP-HPLC, identity by mass spec
- Volume pricing from 10 vials
Retatrutide is a lyophilized research peptide for controlled laboratory investigation of multi-receptor signaling across the GLP-1, GIP, and glucagon pathways. Material is documented at the lot level, with independent analytical results published in the ALORA COA directory.
For in-vitro receptor pharmacology, binding assays, and comparative triple-agonist pathway studies under institutional research protocols.
- Catalog code
- ALO-P-003
- Form
- Lyophilized powder
- Molecular formula
- C223H343F3N48O64
- Molecular weight
- 4731.3 g/mol
- Classification
- Research peptide — laboratory use only
Store lyophilized at −20°C. Protect from light and moisture.
Handle using standard laboratory PPE and aseptic technique. Reconstitute only under controlled research conditions.
Laboratory handling guide →Sold strictly for in-vitro laboratory research by qualified purchasers aged 21 or older. We don’t provide dosing, administration or human-use guidance.
Read the research-use policy →
